Antoine Barraud

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Linköping University Hospital provides healthcare services.

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Avaloq Group AG specializes in electronic data processing, development and distribution of software and hardware, as well as outsourcing services. It acquires, holds, manages, and disposes real estate properties and intellectual property rights. The company was founded on April 10, 1993 and is headquartered in Freienbach, Switzerland.

Avaloq Evolution AG provides banking software services and solutions. Its services include safeguarding, consulting, training, support, and maintenance. The company was founded in 1991 and is headquartered in Zurich, Switzerland.

Sensile Technologies SA provides solutions for remote monitoring of meters and tank levels for the oil and gas industries. The firm offers its solutions for gas tank, oil and lubricant tank, petrol station, gas cylinders and meter. The company was founded by Sigfrid Strässler and Peter Ryser in 1999 and is headquartered in Morges, Switzerland.

uniqFEED AG engages in a software company. It develops software for Virtual Advertising Technology or Digital Replacement Technology (DRT) in live sports on television. The company was founded by Lukas Gysin and Ralf Dragon in 2015 and is headquartered in Zurich, Switzerland.

GlucoModicum Oy is a company based in Helsinki, FI that is transforming glucose monitoring with precise, needle-free magnetohydrodynamic technology. GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and combines an experienced, multi-disciplinary in-house team with world-class partners to deliver groundbreaking solutions for personal biomarker monitoring. The Finnish company's proprietary platform has the potential to radically change how people monitor their health, creating solutions that are precise, accessible, and needle-free, empowering people to live healthier lives. The company's first product is a non-invasive, wearable glucose monitor for patients suffering from diabetes. The company was founded in 2018 by Johan Bobacka. The CEO is Jokke Mäki.

bNovate Technologies SA is a water monitoring company based in Ecublens, Switzerland. The Swiss company specializes in developing custom-made instruments for clients and creating cell detection instruments for drinking water. The company's innovative water monitoring solutions include bactosense, bactosense multi, and aqu@sense, which can be used for multi-point water monitoring to detect bacteria in water throughout the water process line. The company also offers solutions for monitoring the purification steps of drinking water treatment, such as pre-treatment and filtration, with bactosense online and bactosense multi. Additionally, they provide aqu@sense mb for taking control of the microbiological quality of pharmaceutical water supplies. The company was founded in 2011 by Simon Künzi.

Berkshire Biomedical LLC is a medical device company that is pioneering the use of biometric technologies to provide precise and accurate personalized medication delivery to only the authenticated intended user. The private company is based in Dallas, TX. The company's lead product under development is the computerized oral prescription administration system (COPA), a hand-held, automated, personalized oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the authenticated intended user upon confirmation of dual biometric identification. The company was founded in 2016 by Thomas M. Rouse, Susan Owen. John E. Timberlake has been the CEO of the company since 2021.